Literature DB >> 22387016

Mutations in CTC1, encoding the CTS telomere maintenance complex component 1, cause cerebroretinal microangiopathy with calcifications and cysts.

Anne Polvi1, Tarja Linnankivi, Tero Kivelä, Riitta Herva, James P Keating, Outi Mäkitie, Davide Pareyson, Leena Vainionpää, Jenni Lahtinen, Iiris Hovatta, Helena Pihko, Anna-Elina Lehesjoki.   

Abstract

Cerebroretinal microangiopathy with calcifications and cysts (CRMCC) is a rare multisystem disorder characterized by extensive intracranial calcifications and cysts, leukoencephalopathy, and retinal vascular abnormalities. Additional features include poor growth, skeletal and hematological abnormalities, and recurrent gastrointestinal bleedings. Autosomal-recessive inheritance has been postulated. The pathogenesis of CRMCC is unknown, but its phenotype has key similarities with Revesz syndrome, which is caused by mutations in TINF2, a gene encoding a member of the telomere protecting shelterin complex. After a whole-exome sequencing approach in four unrelated individuals with CRMCC, we observed four recessively inherited compound heterozygous mutations in CTC1, which encodes the CTS telomere maintenance complex component 1. Sanger sequencing revealed seven more compound heterozygous mutations in eight more unrelated affected individuals. Two individuals who displayed late-onset cerebral findings, a normal fundus appearance, and no systemic findings did not have CTC1 mutations, implying that systemic findings are an important indication for CTC1 sequencing. Of the 11 mutations identified, four were missense, one was nonsense, two resulted in in-frame amino acid deletions, and four were short frameshift-creating deletions. All but two affected individuals were compound heterozygous for a missense mutation and a frameshift or nonsense mutation. No individuals with two frameshift or nonsense mutations were identified, which implies that severe disturbance of CTC1 function from both alleles might not be compatible with survival. Our preliminary functional experiments did not show evidence of severely affected telomere integrity in the affected individuals. Therefore, determining the underlying pathomechanisms associated with deficient CTC1 function will require further studies. Copyright Â
© 2012 The American Society of Human Genetics. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22387016      PMCID: PMC3309194          DOI: 10.1016/j.ajhg.2012.02.002

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  34 in total

1.  Prediction of deleterious human alleles.

Authors:  S Sunyaev; V Ramensky; I Koch; W Lathe; A S Kondrashov; P Bork
Journal:  Hum Mol Genet       Date:  2001-03-15       Impact factor: 6.150

Review 2.  A perfect message: RNA surveillance and nonsense-mediated decay.

Authors:  M W Hentze; A E Kulozik
Journal:  Cell       Date:  1999-02-05       Impact factor: 41.582

3.  Telomere measurement by quantitative PCR.

Authors:  Richard M Cawthon
Journal:  Nucleic Acids Res       Date:  2002-05-15       Impact factor: 16.971

Review 4.  The Finnish Disease Heritage III: the individual diseases.

Authors:  Reijo Norio
Journal:  Hum Genet       Date:  2003-03-08       Impact factor: 4.132

5.  A familial syndrome with coats' reaction retinal angiomas, hair and nail defects and intracranial calcification.

Authors:  J L Tolmie; B H Browne; P M McGettrick; J B Stephenson
Journal:  Eye (Lond)       Date:  1988       Impact factor: 3.775

6.  Extensive brain calcifications, leukodystrophy, and formation of parenchymal cysts: a new progressive disorder due to diffuse cerebral microangiopathy.

Authors:  P Labrune; C Lacroix; F Goutières; J de Laveaucoupet; P Chevalier; M Zerah; B Husson; P Landrieu
Journal:  Neurology       Date:  1996-05       Impact factor: 9.910

7.  Leukoencephalopathy, cerebral calcifications, and cysts: new observations.

Authors:  L M Nagae-Poetscher; G Bibat; M Philippart; S Rosemberg; A Fatemi; M T C Lacerda; M O R Costa; F Kok; C Costa Leite; A Horská; P B Barker; S Naidu
Journal:  Neurology       Date:  2004-04-13       Impact factor: 9.910

8.  Coats' plus: a progressive familial syndrome of bilateral Coats' disease, characteristic cerebral calcification, leukoencephalopathy, slow pre- and post-natal linear growth and defects of bone marrow and integument.

Authors:  Y J Crow; J McMenamin; C A Haenggeli; D M Hadley; S Tirupathi; E P Treacy; S M Zuberi; B H Browne; J L Tolmie; J B P Stephenson
Journal:  Neuropediatrics       Date:  2004-02       Impact factor: 1.947

Review 9.  Shelterin: the protein complex that shapes and safeguards human telomeres.

Authors:  Titia de Lange
Journal:  Genes Dev       Date:  2005-09-15       Impact factor: 12.890

10.  Comparison of solution-based exome capture methods for next generation sequencing.

Authors:  Anna-Maija Sulonen; Pekka Ellonen; Henrikki Almusa; Maija Lepistö; Samuli Eldfors; Sari Hannula; Timo Miettinen; Henna Tyynismaa; Perttu Salo; Caroline Heckman; Heikki Joensuu; Taneli Raivio; Anu Suomalainen; Janna Saarela
Journal:  Genome Biol       Date:  2011-09-28       Impact factor: 13.583

View more
  72 in total

Review 1.  The molecular genetics of the telomere biology disorders.

Authors:  Alison A Bertuch
Journal:  RNA Biol       Date:  2015-09-23       Impact factor: 4.652

2.  Human TEN1 maintains telomere integrity and functions in genome-wide replication restart.

Authors:  Christopher Kasbek; Feng Wang; Carolyn M Price
Journal:  J Biol Chem       Date:  2013-09-11       Impact factor: 5.157

3.  CTC1 Mutations in a patient with dyskeratosis congenita.

Authors:  Rachel B Keller; Katelyn E Gagne; G Naheed Usmani; George K Asdourian; David A Williams; Inga Hofmann; Suneet Agarwal
Journal:  Pediatr Blood Cancer       Date:  2012-04-24       Impact factor: 3.167

4.  CTC1 deletion results in defective telomere replication, leading to catastrophic telomere loss and stem cell exhaustion.

Authors:  Peili Gu; Jin-Na Min; Yang Wang; Chenhui Huang; Tao Peng; Weihang Chai; Sandy Chang
Journal:  EMBO J       Date:  2012-04-24       Impact factor: 11.598

5.  Sequential phosphorylation of CST subunits by different cyclin-Cdk1 complexes orchestrate telomere replication.

Authors:  Veena Gopalakrishnan; Cherylin Ruiling Tan; Shang Li
Journal:  Cell Cycle       Date:  2017-06-26       Impact factor: 4.534

Review 6.  Shaping human telomeres: from shelterin and CST complexes to telomeric chromatin organization.

Authors:  Ci Ji Lim; Thomas R Cech
Journal:  Nat Rev Mol Cell Biol       Date:  2021-02-09       Impact factor: 94.444

Review 7.  Telomeres and age-related disease: how telomere biology informs clinical paradigms.

Authors:  Mary Armanios
Journal:  J Clin Invest       Date:  2013-03-01       Impact factor: 14.808

8.  Response to androgen therapy in patients with dyskeratosis congenita.

Authors:  Payal P Khincha; Ingrid M Wentzensen; Neelam Giri; Blanche P Alter; Sharon A Savage
Journal:  Br J Haematol       Date:  2014-02-12       Impact factor: 6.998

9.  Human CST Prefers G-Rich but Not Necessarily Telomeric Sequences.

Authors:  Robert A Hom; Deborah S Wuttke
Journal:  Biochemistry       Date:  2017-08-02       Impact factor: 3.162

10.  Tying up the Ends: Plasticity in the Recognition of Single-Stranded DNA at Telomeres.

Authors:  Neil R Lloyd; Thayne H Dickey; Robert A Hom; Deborah S Wuttke
Journal:  Biochemistry       Date:  2016-09-15       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.